Please use this identifier to cite or link to this item:
http://acervodigital.unesp.br/handle/11449/64649
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lastoria, Joel Carlos | - |
dc.contributor.author | Marques, Silvio Alencar | - |
dc.contributor.author | Dillon, N. L. | - |
dc.contributor.author | Lastoria, S. | - |
dc.contributor.author | Curi, P. R. | - |
dc.date.accessioned | 2014-05-27T11:18:01Z | - |
dc.date.accessioned | 2016-10-25T18:13:36Z | - |
dc.date.available | 2014-05-27T11:18:01Z | - |
dc.date.available | 2016-10-25T18:13:36Z | - |
dc.date.issued | 1995-12-01 | - |
dc.identifier | http://cat.inist.fr/?aModele=afficheN&cpsidt=2955274 | - |
dc.identifier.citation | Medicina Cutanea Ibero-Latino-Americana, v. 23, n. 8, p. 377-382, 1995. | - |
dc.identifier.issn | 0210-5187 | - |
dc.identifier.uri | http://hdl.handle.net/11449/64649 | - |
dc.identifier.uri | http://acervodigital.unesp.br/handle/11449/64649 | - |
dc.description.abstract | The authors studied the incidence of thrombophlebitis in 41 patients treated intravenously with amphotericin B. The patients were divided in two different group: Group 1: patients treated with amphotericin B and hydrocortisone with heparin (1000 UI); Group 2: patients treated with amphotericin B and hydrocortisone. The results showed 23.81% of incidence of thrombophlebitis in Group 1 and 90% in Group 2. Thrombophlebitis in Group 1 ranged from mild to moderate without any change during the drug therapy. In Group 2, the incidence was 66.67% and the thrombophlebitis were severe being necessary the withdrawn of the drugs in 35.0% of the cases. We concluded that heparin, in low doses, in association with amphotericin B, was an efficient drug preventing or reducing the development of thrombophlebitis. | en |
dc.format.extent | 377-382 | - |
dc.language.iso | por | - |
dc.source | Scopus | - |
dc.subject | amphotericin B | - |
dc.subject | heparin | - |
dc.subject | thrombophlebitis | - |
dc.subject | amphotericin b | - |
dc.subject | hydrocortisone | - |
dc.subject | adolescent | - |
dc.subject | adult | - |
dc.subject | aged | - |
dc.subject | clinical article | - |
dc.subject | clinical trial | - |
dc.subject | controlled clinical trial | - |
dc.subject | controlled study | - |
dc.subject | drug effect | - |
dc.subject | female | - |
dc.subject | human | - |
dc.subject | incidence | - |
dc.subject | male | - |
dc.title | PREVENCAO DE TROMBOFLEBITES PELO USO DE HEPARINA EM PACIENTES TRATADOS COM ANFOTERICINA B | pt |
dc.title.alternative | Prevention of thrombophlebitis with the use of heparin in patients treated with amphotericin B | en |
dc.type | outro | - |
dc.contributor.institution | Universidade Estadual Paulista (UNESP) | - |
dc.description.affiliation | Faculdade de Medicina Departamento de Dermatologia, Rubiao Jr., CEP 18618-000 Botucatu, SP | - |
dc.rights.accessRights | Acesso restrito | - |
dc.relation.ispartof | Medicina Cutanea Ibero-Latino-Americana | - |
dc.identifier.scopus | 2-s2.0-0029616720 | - |
Appears in Collections: | Artigos, TCCs, Teses e Dissertações da Unesp |
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.